Overview

Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet

Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether PG-DN-20WS is a better pain reliever in patients with diabetic neuropathic pain of the feet than a placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Pure Green